ArticleAmerican journal of translational research2023
Diagnostic efficacy of ultrasound elastography and dynamic contrast-enhanced MR in benign and malignant breast masses.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Navigating the diagnostic pitfalls of cystic and solid breast masses: a comparative case report of metaplastic carcinoma and benign lesions.Frontiers in oncology · 2026Article
- The diagnostic value of real-time ultrasound elastography and contrast-enhanced ultrasound in BI-RADS 4A breast lesions.Gland surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the diagnostic efficacy of ultrasound elastography (UE) and dynamic contrast-enhanced MR in benign and malignant breast masses.
methodsFrom August 2016 to May 2019, the medical records of 98 patients with breast masses in the Zhuji Sixth People's Hospital were retrospectively analyzed, including 45 cases of benign tumor and 53 cases of malignancy diagnosed by pathology. All patients were examined by UE and dynamic contrast-enhanced MR imaging. The pathologic results were used as the gold standard, and the detection results of benign and malignant masses under different examinations were observed and compared with pathology to analyze the specificity and sensitivity.
resultsThe specificity and sensitivity of diagnosis by UE were 94.44% and 86.89% respectively. The specificity and sensitivity of diagnosis by dynamic contrast-enhanced MR imaging were 96.30% and 91.80%, respectively. The specificity and sensitivity of joint diagnosis were 98.36% and 90.74%, respectively.
conclusionJoint diagnosis can improve the sensitivity in the diagnosis of benign and malignant breast masses. This improves the diagnostic value for breast tumors.
Indexed as
Identifiers
37193163PMC10182532W4376871596What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.